First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States

Antimicrob Agents Chemother. 2008 Jun;52(6):2244-6. doi: 10.1128/AAC.00231-08. Epub 2008 Apr 7.

Abstract

Linezolid resistance has dominantly been mediated by mutations in 23S rRNA or ribosomal protein L4 genes. Recently, cfr has demonstrated the ability to produce a phenotype of resistance to not only oxazolidinones, but also other antimicrobial classes (phenicols, lincosamides, pleuromutilins, and streptogramin A). We describe the first detection of cfr-mediated linezolid resistance in Staphylococcus aureus and Staphylococcus epidermidis recovered from human infection cases monitored during the 2007 LEADER Program.

MeSH terms

  • Acetamides / pharmacology*
  • Anti-Bacterial Agents / pharmacology
  • Anti-Infective Agents / pharmacology*
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism
  • Drug Resistance, Bacterial / genetics*
  • Humans
  • Linezolid
  • Methyltransferases / genetics*
  • Methyltransferases / metabolism
  • Microbial Sensitivity Tests
  • Molecular Sequence Data
  • Oxazolidinones / pharmacology*
  • Sequence Analysis, DNA
  • Staphylococcal Infections / microbiology
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / enzymology
  • Staphylococcus aureus / genetics
  • Staphylococcus epidermidis / drug effects*
  • Staphylococcus epidermidis / enzymology
  • Staphylococcus epidermidis / genetics

Substances

  • Acetamides
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Bacterial Proteins
  • Oxazolidinones
  • Methyltransferases
  • Linezolid

Associated data

  • GENBANK/EU598691